Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-23T21:57:01.903Z Has data issue: false hasContentIssue false
  • English
  • Français

Affective Impairment in Schizophrenia: Depression/Anxiety

Published online by Cambridge University Press:  07 November 2014

Peter F. Buckley
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Clinical Information Monograph
Information
CNS Spectrums , Volume 10 , Issue 2 , February 2005 , pp. 4 - 6
Copyright
Copyright © Cambridge University Press 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Green, AI, Canuso, CM, Brenner, MJ, Wojeik, JD. Detection and management of comorbidity in patients with schizophrenia. Psychiatr Clin N Am. 2003;26(1):1.CrossRefGoogle ScholarPubMed
2.McGlashan, TH, Carpenter, WT. Postpsychotic depression in schizophrenia. Arch Gen Psychiatry. 1976;33:231–239.Google Scholar
3.Birchwood, M, Iqbal, Z, Chadwick, P, Trower, P. Cognitive approach to depression and suicidal thinking in psychosis: 1. ontogeny of post-psychotic depression. Br J Psychiatry. 2000;177:516–521.CrossRefGoogle ScholarPubMed
4.Siris, SG. Depression in schizophrenia: perspective in the era of atypical antipsychotic agents. Am J Psychiatry. 2000;157:1379–1389.CrossRefGoogle ScholarPubMed
5.Emsley, R, Buckley, PF, Jones, AM, Greenwood, MR. Differential effect of quetiapine on depressive symptoms in patients with partially responsive schizophrenia. J Psychopharmacol. 2003;17(2):210–215.CrossRefGoogle ScholarPubMed
6.Lehman, AF, Kreyenbuhl, J, Buchanan, RW, et al.The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003. Schizophr Bull. 2004;30(2):193–217.CrossRefGoogle ScholarPubMed
7. Depression and Suicide in Schizophrenia. Mental Illness Research, Education and Clinical Center Web site. Available at: http://www.mirecc.org/science-articles/suicide-and-depression-archive.shtml. Accessed: January 2005.Google Scholar
8.Poyurovsky, M, Kriss, V, Weisman, G, et al.Comparison of clinical characteristics and comorbidity in schizophrenia patients with and without obsessive-compulsive disorder: schizophrenic and OC symptoms in schizophrenia. J Clin Psychiatry. 2003;64:1300–1307.CrossRefGoogle ScholarPubMed
9.Siris, SG, Morgan, V, Fagerstrom, R, Rifkin, A, Coooper, TB. Adjunctive imipramine in the treatment of postpsychotic depression: a controlled trial. Arch Gen Psychiatry. 1987;44:533–539.Google Scholar
10.Kirli, S, Caliskan, M. A comparative study of sertraline versus imipramine in postpsychotic depressive disorder of schizophrenia. Schizophr Res. 1998;33:103–111.Google Scholar
11.Hwang, MY, Opler, LA. Management of schizophrenia with obsessive-compulsive disorder. Psychiatr Ann. 2000;30:23–28.CrossRefGoogle Scholar
12.Buckley, PF, Sajatovic, M, Meltzer, HY. Treatment of delusional disorders with clozapine. Am J Psychiatry. 1994;151:1394–1395.Google ScholarPubMed
13.Meltzer, HY, Alphs, L, Green, AI, et al.Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trail (InterSePT). Arch Gen Psychiatry. 2003;60(1):82–91.Google Scholar